Literature DB >> 3424957

Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.

H Bounameaux, P A Schneider, A Mossaz, P Suter, H Vasey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3424957

Source DB:  PubMed          Journal:  Vasa        ISSN： 0301-1526            Impact factor:   1.961


× No keyword cloud information.
  3 in total

1.  Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells.

Authors:  Ling Ling; Emily T Camilleri; Torben Helledie; Rebekah M Samsonraj; Drew M Titmarsh; Ren Jie Chua; Oliver Dreesen; Christian Dombrowski; David A Rider; Mario Galindo; Ian Lee; Wanjin Hong; James H Hui; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  Gene       Date:  2015-10-17       Impact factor: 3.688

Review 2.  The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications.

Authors:  Bethanie I Ayerst; Catherine L R Merry; Anthony J Day
Journal:  Pharmaceuticals (Basel)       Date:  2017-06-13

3.  Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering Applications.

Authors:  Bethanie I Ayerst; Raymond A A Smith; Victor Nurcombe; Anthony J Day; Catherine L R Merry; Simon M Cool
Journal:  Tissue Eng Part A       Date:  2017-01-06       Impact factor: 3.845
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.